This alert about Amylin's Byetta is from 2007. Then it was only an FDA alert, but today FDA updated the information about Amylin's Byetta and warns of the diabetes drug, saying that Byetta has a potential risk for pancreatitis.
As you watch this video, you can see the same problem of the Byetta diabetes drug one year ago as an alter, but today the issue is more serious. Byetta has already killed two patients, says FDA.
Analysts are telling investors to stay away from the name Amylins due to the strong FDA warning.
Posted August 18th, 2008 by erku
